FBXO42 Antibodies

Santa Cruz Biotechnology features a diverse variety of FBXO42 monoclonal antibodies for research focused on understanding FBXO42's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO42 is a member of the F-box protein family, which plays a crucial role in the ubiquitin-proteasome pathway, a key mechanism for protein degradation and regulation within the cell. FBXO42 is involved in the modulation of various cellular functions, including cell cycle progression and signal transduction. Research on FBXO42 has significant implications for understanding cancer and other diseases. FBXO42 continues to emerge as a promising therapeutic target, with ongoing studies revealing new aspects of its biological significance. Investigating FBXO42 can provide valuable insights into cellular regulatory mechanisms and disease pathways. Research utilizing Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific understanding of FBXO42's role in human health and disease.